glp 1 for ms patients The Role of Glucagon-Like Peptide-1 Agonists in the Treatment of Multiple Sclerosis: A Narrative Review GLP1 – Medical Students for

PMCID: PMC5845358

This large-scale evidence supports our narrative review published in 2025, in which we suggested a connection between GLP-1RAs and addiction based on the limited evidence available in the literature at that time

For people considering long-term GLP-1 use, the safety data is encouraging

(Folate deficiency disrupts normal DNA synthesis and methylation, which interferes with cell division and development, especially in rapidly dividing embryos.) Megaloblastic anemia, which can lead to symptoms like fatigue, weakness, and difficulty concentrating Elevated homocysteine, even when B12 levels are normal

Microb Cell Fact 9:3239 Yoshida K, Hariki T, Inoue H, Nakamura T (2002) External skin preparation for whitening